A team at UCF’s Center for Research in Computer Vision have created an system that can detect trace amounts of lung cancer with 95 percent accuracy.
Doctors may soon have help in the fight against cancer thanks to the UCF’s Center for Research in Computer Vision.
Engineers at the center have taught a computer how to detect tiny specks of lung cancer in CT scans, which radiologists often have a difficult time identifying. The artificial intelligence system is about 95 percent accurate, compared to 65 percent when done by human eyes, the team says.
“We used the brain as a model to create our system.” – Rodney LaLonde, a doctoral candidate
“We used the brain as a model to create our system,” says Rodney LaLonde, a doctoral candidate and captain of UCF’s hockey team. “You know how connections between neurons in the brain strengthen during development and learn? We used that blueprint, if you will, to help our system understand how to look for patterns in the CT scans and teach itself how to find these tiny tumors.”
The approach is similar to the algorithms that facial-recognition software uses. It scans thousands of faces looking for a particular pattern to find its match.
Engineering Assistant Professor Ulas Bagci leads the group of researchers in the center that focuses on AI with potential medical applications.
The group fed more than 1,000 CT scans – provided by the National Institutes of Health through a collaboration with the Mayo Clinic – into the software they developed to help the computer learn to look for the tumors.
Graduate students working on the project had to teach the computer different things to help it learn properly. Naji Khosravan, who is pursuing his doctorate degree, created the backbone of the system of learning. His proficiency at novel machine learning and computer vision algorithms led to his summer as an intern at Netflix helping the company with various projects.
“Lung cancer is the number one cancer killer in the United States and if detected in late stages, the survival rate is only 17 percent.” – Engineering Assistant Professor Ulas Bagci
LaLonde taught the computer how to ignore other tissue, nerves and other masses it encountered in the CT scans and analyze lung tissues. Sarfaraz Hussein who earned his doctorate degree this past summer, is fine-tuning the AI’s ability to identify cancerous versus benign tumors, while graduate student Harish Ravi Parkash is taking lessons learned from this project and applying them see if another AI system can be developed to help identify or predict brain disorders.
“I believe this will have a very big impact,” Bagci says. “Lung cancer is the number one cancer killer in the United States and if detected in late stages, the survival rate is only 17 percent. By finding ways to help identify earlier, I think we can help increase survival rates.”
The team will present its finding in September at the largest premier conference for medical imaging research – the MICCAI 2018 conference in Spain. The team’s work has been published in advance of the conference.
The next step is to move the research project into a hospital setting; Bagci is looking for partners to make that happen. After that, the technology could be a year or two away from the marketplace, Bagci says.
“I think we all came here because we wanted to use our passion for engineering to make a difference and saving lives is a big impact,” LaLonde says.
Ravi Prakash agrees. He was studying engineering and its applications to agriculture before he heard about Bagci and his work at UCF. Bagci’s research is in the area of biomedical imaging and machine learning and their applications in clinical imaging. Previously, Bagci was a staff scientist and the lab manager at the NIH’s Center for Infectious Disease Imaging lab, in the department of Radiology and Imaging Sciences.
Learn more: Engineers Develop A.I. System to Detect Often-Missed Cancer Tumors
The Latest on: Artificial intelligence diagnostics
[google_news title=”” keyword=”artificial intelligence diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial intelligence diagnostics
- Progressive Role of Artificial Intelligence in Treatment Decision - Making in the Field of Medical Oncologyon May 8, 2024 at 2:49 am
Artificial intelligence (AI) has started to play an important role in oncologic medicine today, focusing mainly on oncologic diagnosis (by helping in cancer radiology & pathology) and radiation ...
- Quest Diagnostics (DGX) Grows in Digital Pathology With New Dealon May 7, 2024 at 8:23 am
Quest Diagnostics DGX recently announced a strategic collaboration with PathAI, a global leader in artificial intelligence-powered pathology technology, aimed at revolutionizing cancer and disease ...
- Quest plans to purchase PathAI’s diagnostic lab as part of AI ramp-upon May 6, 2024 at 9:18 am
AI and digital technologies have tremendous potential to improve cancer care, and Quest has the know-how to scale and deliver innovations that are high quality, efficient and broadly accessible," said ...
- Artificial Intelligence in Diagnostics Market CAGR of 32.3%, Size Poised for Takeoff in the Coming Yearson May 5, 2024 at 2:43 pm
Artificial Intelligence in Diagnostics Market is valued approximately at USD 288 million in 2019 and is anticipated to grow with a healthy growth rate of more than 32.3% over the forecast period ...
- Artificial intelligence expands diagnostic horizons in coronary angiographyon May 3, 2024 at 6:46 am
New insights from the AI-ENCODE study showed artificial intelligence (AI) successfully allowed the ... Coronary angiography is a widely used diagnostic procedure for identifying coronary artery ...
- Quest Finds its Path to AI in Cancer Diagnostics Through M&Aon May 1, 2024 at 10:25 am
Quest Diagnostics has found its path to artificial intelligence in cancer diagnosis through M&A. The Secaucus NJ-based company said it was acquiring select assets of PathAI Diagnostics, the business ...
- 16 Surprising Ways AI Enhances Healthcare Diagnostics And Deliveryon May 1, 2024 at 10:14 am
Many patients might be surprised to learn just how big an impact AI is poised to make in modern healthcare delivery.
- Quest Diagnostics carves out PathAI's digital pathology lab, plots AI ramp-upon May 1, 2024 at 7:30 am
Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multi-layered deal with PathAI—acquiring some assets, licensing out others. | Quest ...
- Quest Diagnostics To Acquire Select Assets Of PathAI Diagnostics - Quick Factson May 1, 2024 at 4:31 am
Quest Diagnostics (DGX) and PathAI, a global provider of artificial intelligence-powered technology for pathology, announced ...
- Artificial Intelligence in Diagnostics Market To Reach USD 7.8 Billion By 2032 | DataHorizzon Researchon April 30, 2024 at 11:40 pm
The artificial intelligence in diagnostics market size valued at USD 0.7 Billion in 2022 and is anticipated to reach USD 7.8 Billion by 2032 at a CAGR of 26.4%.Fort Collins, Colorado, May 01, 2024 ...
via Bing News